Analysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review.

Authors:
Nieddu M; Baralla E; Sodano F; Boatto G.

Journal:
Forensic Toxicol

Publication Year: 2022

DOI:
10.1007/s11419-022-00638-6

PMCID:
PMC9849320

PMID:
36652064

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Forensic Toxicol

Abbreviation: Forensic Toxicol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Forensic Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a buc…
Neukamm MA; Halter S; Auwärter V and 3 more (2023) - Transparency Score: 3/6
Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products.
Tanaka R; Kawamura M; Mizutani S and 1 more (2023) - Transparency Score: 3/6
Urinary profiles of methoxyphenamine and its metabolite after inhalation of methoxyphenamine smoke …
Morinaka H; Kaizaki-Mitsumoto A; Morohoshi H and 2 more (2023) - Transparency Score: 5/6
Analysis of degradation products of Novichok agents in human urine by hydrophilic interaction liqui…
Otsuka M; Yamaguchi A; Miyaguchi H. (2022) - Transparency Score: 3/6
A review of synthetic cathinones emerging in recent years (2019-2022).
Kuropka P; Zawadzki M; Szpot P. (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare that they have no conflict of interest. Ethical approvalThis article does not contain any studies with human participants or animals performed by any of the authors. Conflict of interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding Open access funding provided by Università degli Studi di Sassari within the CRUI-CARE Agreement."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025